Health Condition 1: null- ORAL SUBMUCOSAL FIBROSIS
Conditions
Interventions
Intervention1: SNEC30 (Curcumin Therapy): Each 900 mg capsule contains:-
SNEC30 (Curcuma Longa) Eq. to Curcuminoids â?¦. 30 mg
Control Intervention1: Conventional treatment: Conventional treatment
C
Sponsors
Arbro Pharmaceuticals Pvt Ltd
Eligibility
Inclusion criteria
Inclusion criteria: 1. Patient or his legally accepted representative is willing to give informed consent. 2. Patient is in the age range of 18-65 yrs. 3. Patient clinically diagnosed with OSF (diagnosed on the basis of reduction in interincisal distance on maximum mouth opening and palpable fibrous bands involving oral mucosa). 4. Patient is willing to discontinue the use of tobacco in any form or areca 1-month prior to the commencement of the treatment.
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Reduction in burning sensation. Improvement in mouth opening. Timepoint: reduction in burning sensation and mouth opening will be checked at enrollment day , day 28, day 56 and day 84. | — |
Secondary
| Measure | Time frame |
|---|---|
| Safety and tolerability of the drug will be evaluated on the basis of occurrence / non-occurrence, type, frequency and duration of drug-related adverse reactionsTimepoint: Safety and tolerability of the drug will be evaluated throughout the study. | — |
Countries
India
Contacts
Public ContactDr Navneet Kumar Gupta
Outcome results
None listed